Strides Pharma Science Limited (STAR.NS)
INR 701.9
(1.52%)
INR 701.9
(1.52%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.22 Billion INR | 755.69% |
| 2022 | -796.99 Million INR | 71.78% |
| 2021 | -2.82 Billion INR | -161.81% |
| 2020 | 4.56 Billion INR | 119.5% |
| 2019 | 2.08 Billion INR | -29.28% |
| 2018 | 2.94 Billion INR | 21.37% |
| 2017 | 2.42 Billion INR | -49.73% |
| 2016 | 4.82 Billion INR | 30.66% |
| 2015 | 3.69 Billion INR | 106.13% |
| 2014 | 1.79 Billion INR | 12.07% |
| 2013 | 1.59 Billion INR | -67.66% |
| 2012 | 4.94 Billion INR | 48.23% |
| 2011 | 3.33 Billion INR | 0.29% |
| 2010 | 3.32 Billion INR | 106.07% |
| 2009 | 1.61 Billion INR | -58.46% |
| 2008 | 3.88 Billion INR | 377.81% |
| 2007 | 812.8 Million INR | -24.28% |
| 2006 | 1.07 Billion INR | 14.98% |
| 2005 | 933.54 Million INR | 10.19% |
| 2004 | 847.2 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.68 Billion INR | -6.44% |
| 2024 Q2 | 1.85 Billion INR | 10.03% |
| 2023 FY | 5.22 Billion INR | 755.69% |
| 2023 Q4 | 1.79 Billion INR | 67.44% |
| 2023 Q3 | 1.07 Billion INR | 22.65% |
| 2023 Q2 | 876.39 Million INR | 9.32% |
| 2023 Q1 | 801.69 Million INR | -0.96% |
| 2022 FY | -796.99 Million INR | 71.78% |
| 2022 Q2 | -312.14 Million INR | 27.56% |
| 2022 Q4 | 809.43 Million INR | 321.66% |
| 2022 Q3 | -365.16 Million INR | -16.99% |
| 2022 Q1 | -430.9 Million INR | -5479.53% |
| 2021 Q3 | -838.97 Million INR | -45.56% |
| 2021 Q1 | -1.1 Billion INR | -202.0% |
| 2021 FY | -2.82 Billion INR | -161.81% |
| 2021 Q2 | -576.37 Million INR | 47.71% |
| 2021 Q4 | 8.01 Million INR | 100.95% |
| 2020 Q2 | 1.04 Billion INR | 2.49% |
| 2020 Q3 | 1.06 Billion INR | 2.37% |
| 2020 Q4 | 1.08 Billion INR | 1.1% |
| 2020 Q1 | 1.01 Billion INR | 133.37% |
| 2020 FY | 4.56 Billion INR | 119.5% |
| 2019 Q1 | 807.2 Million INR | -29.75% |
| 2019 FY | 2.08 Billion INR | -29.28% |
| 2019 Q4 | 436.55 Million INR | -68.22% |
| 2019 Q3 | 1.37 Billion INR | 31.34% |
| 2019 Q2 | 1.04 Billion INR | 29.57% |
| 2018 Q3 | 864.2 Million INR | 56.81% |
| 2018 Q2 | 551.1 Million INR | 45.37% |
| 2018 Q1 | 379.1 Million INR | -10.12% |
| 2018 FY | 2.94 Billion INR | 21.37% |
| 2018 Q4 | 1.14 Billion INR | 32.96% |
| 2017 FY | 2.42 Billion INR | -49.73% |
| 2017 Q4 | 421.8 Million INR | -49.67% |
| 2017 Q3 | 838 Million INR | 9.0% |
| 2017 Q2 | 768.8 Million INR | 112.55% |
| 2017 Q1 | 361.7 Million INR | -65.23% |
| 2016 Q1 | 858.8 Million INR | 29.36% |
| 2016 Q4 | 1.04 Billion INR | -11.05% |
| 2016 Q3 | 1.16 Billion INR | -1.57% |
| 2016 Q2 | 1.18 Billion INR | 38.36% |
| 2016 FY | 4.82 Billion INR | 30.66% |
| 2015 Q2 | 455.43 Million INR | 13.77% |
| 2015 Q1 | 400.3 Million INR | -42.57% |
| 2015 FY | 3.69 Billion INR | 106.13% |
| 2015 Q4 | 663.9 Million INR | -36.26% |
| 2015 Q3 | 1.04 Billion INR | 128.7% |
| 2014 Q3 | 498.12 Million INR | 59.87% |
| 2014 Q2 | 311.58 Million INR | 6.98% |
| 2014 Q1 | 291.24 Million INR | 0.0% |
| 2014 FY | 1.79 Billion INR | 12.07% |
| 2014 Q4 | 696.98 Million INR | 39.92% |
| 2013 FY | 1.59 Billion INR | -67.66% |
| 2012 FY | 4.94 Billion INR | 48.23% |
| 2011 FY | 3.33 Billion INR | 0.29% |
| 2010 FY | 3.32 Billion INR | 106.07% |
| 2009 FY | 1.61 Billion INR | -58.46% |
| 2008 FY | 3.88 Billion INR | 377.81% |
| 2007 FY | 812.8 Million INR | -24.28% |
| 2006 FY | 1.07 Billion INR | 14.98% |
| 2005 FY | 933.54 Million INR | 10.19% |
| 2004 FY | 847.2 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -254.558% |
| Ind-Swift Limited | 1.22 Billion INR | -326.261% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -954.641% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 94.999% |
| Innova Captab Limited | 2.53 Billion INR | -106.276% |
| Divi's Laboratories Limited | 18.31 Billion INR | 71.459% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -16.807% |
| Morepen Laboratories Limited | 4.17 Billion INR | -25.204% |
| Mankind Pharma Limited | 40.86 Billion INR | 87.213% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -206.103% |
| Laurus Labs Limited | 3.94 Billion INR | -32.346% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -34.319% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 41.801% |
| Alembic Limited | 767.77 Million INR | -580.648% |
| Hikal Limited | 1.49 Billion INR | -249.74% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 9.244% |
| Neuland Laboratories Limited | 5.31 Billion INR | 1.735% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 30.707% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 19.632% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -5.739% |
| Themis Medicare Limited | 1.3 Billion INR | -301.028% |
| RPG Life Sciences Limited | 2.29 Billion INR | -127.972% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 88.487% |
| Lupin Limited | 27.75 Billion INR | 81.174% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -741.479% |
| Wockhardt Limited | 140 Million INR | -3632.721% |
| Vaishali Pharma Limited | 6.29 Million INR | -82928.44% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -67.059% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -2341.511% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -0.709% |
| FDC Limited | 3.03 Billion INR | -72.256% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 92.284% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2411.805% |
| Eris Lifesciences Limited | 5.18 Billion INR | -0.851% |
| Venus Remedies Limited | 534.65 Million INR | -877.425% |
| ZIM Laboratories Limited | 1.09 Billion INR | -375.89% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -324.517% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -847.41% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 27.673% |
| Shilpa Medicare Limited | 3.76 Billion INR | -38.926% |
| Albert David Limited | 1.33 Billion INR | -291.606% |
| Ajanta Pharma Limited | 19.67 Billion INR | 73.442% |
| Hester Biosciences Limited | 364.77 Million INR | -1332.632% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -13.416% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 235.633% |
| Gufic Biosciences Limited | 2.89 Billion INR | -80.586% |
| Windlas Biotech Limited | 1.29 Billion INR | -302.329% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -87.574% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -184503.716% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -18932.013% |
| Granules India Limited | 6.52 Billion INR | 19.951% |
| Aarti Drugs Limited | 7.14 Billion INR | 26.899% |
| Bal Pharma Limited | 214.56 Million INR | -2335.492% |
| Alkem Laboratories Limited | 19.46 Billion INR | 73.149% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 94.99% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -174.13% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -2098.85% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -25199.235% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -121.332% |
| Medico Remedies Limited | 277.11 Million INR | -1785.771% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -160.116% |
| Ipca Laboratories Limited | 29.59 Billion INR | 82.343% |
| Brooks Laboratories Limited | -72.25 Million INR | 7332.755% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1996.605% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 79.373% |
| NATCO Pharma Limited | 25.96 Billion INR | 79.871% |
| Suven Life Sciences Limited | -1.22 Billion INR | 526.311% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Indoco Remedies Limited | 1.52 Billion INR | -242.811% |
| Alpa Laboratories Limited | 61.51 Million INR | -8395.18% |
| Lasa Supergenerics Limited | -458 Million INR | 1240.994% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 226.993% |